{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-118988","form_type":"8-K","ticker":"AMRN","cik":"0000897448","company_name":"AMARIN CORP PLCUK","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.322631+00:00","generated_at":"2026-05-30T08:47:35.184955+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Amarin Q3 net revenue $42.3M (-36% YoY); European revenue grows, U.S. declines on generic competition","bullets":["Total net revenue $42.3M (-36% YoY); U.S. net product revenue $30.6M (-51%) from generic competition and CVS delisting.","European net product revenue $4.3M (up from $0.8M); VAZKEPA sales grew 19% sequentially in Spain and UK.","Net loss $25.1M ($0.06/share) vs $19.3M loss ($0.05); non-GAAP adjusted net loss $20.4M ($0.05).","Cash and investments $305.7M, flat QoQ; reaffirms cash adequate for foreseeable future.","Company committed to maintaining public listing; exploring paths to resolve issue. Virtual Analyst Day Nov 14."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-118988","json":"https://secwatch.observer/filing/0000950170-24-118988.json","markdown":"https://secwatch.observer/filing/0000950170-24-118988.md","text":"https://secwatch.observer/filing/0000950170-24-118988.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/897448/000095017024118988/0000950170-24-118988-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/897448/000095017024118988/amrn-20241030.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:47:35.184955+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}